# Type 2 Diabetes Mellitus

## Overview
Type 2 diabetes is a metabolic disorder characterized by high blood sugar, insulin resistance, and relative insulin deficiency.

## Key Information
- **ICD-10 Code**: E11
- **Prevalence**: ~10% of US adults
- **Age of Onset**: Typically >40 years, but increasing in younger populations

## Pathophysiology
- Progressive insulin resistance
- Beta-cell dysfunction
- Increased hepatic glucose production

## Clinical Presentation

### Symptoms
- Polyuria (excessive urination)
- Polydipsia (excessive thirst)
- Polyphagia (excessive hunger)
- Unexplained weight loss
- Fatigue
- Blurred vision

### Physical Findings
- Acanthosis nigricans
- Diabetic retinopathy
- Peripheral neuropathy signs

## Diagnostic Criteria

```mermaid
graph TD
    A[Suspected Diabetes] --> B{Fasting Glucose}
    B -->|≥126 mg/dL| C[Diabetes Confirmed]
    B -->|100-125 mg/dL| D[Prediabetes]
    B -->|<100 mg/dL| E{HbA1c Available?}
    E -->|Yes| F{HbA1c Level}
    F -->|≥6.5%| C
    F -->|5.7-6.4%| D
    F -->|<5.7%| G[Normal]
    E -->|No| H[Consider OGTT]
```

## Treatment Algorithm

```mermaid
graph TD
    A[Newly Diagnosed T2DM] --> B{HbA1c <7%?}
    B -->|No| C[Lifestyle + Metformin]
    C --> D{HbA1c Goal Met?}
    D -->|No| E[Add Second Agent]
    E --> F{CVD Risk High?}
    F -->|Yes| G[Add SGLT2i or GLP-1 RA]
    F -->|No| H[Add Sulfonylurea or DPP-4i]
    D -->|Yes| I[Continue Current Therapy]
    B -->|Yes| J[Lifestyle Modifications]
```

## Management

### Lifestyle Modifications
- **Diet**: Mediterranean or DASH diet
- **Exercise**: 150 minutes moderate activity/week
- **Weight**: Target 5-10% weight loss if overweight

### Pharmacological Treatment

#### First-Line
- **Metformin**: 500-1000mg BID
  - Contraindications: eGFR <30, severe heart failure
  - Side effects: GI upset, lactic acidosis (rare)

#### Second-Line Options
- **SGLT2 Inhibitors**: Empagliflozin, Dapagliflozin
- **GLP-1 Receptor Agonists**: Semaglutide, Liraglutide
- **Sulfonylureas**: Glipizide, Glyburide
- **DPP-4 Inhibitors**: Sitagliptin, Linagliptin

## Monitoring

### Regular Assessments
- **HbA1c**: Every 3-6 months
- **Blood Pressure**: Each visit
- **Lipid Profile**: Annually
- **Microalbumin**: Annually
- **Diabetic Eye Exam**: Annually
- **Foot Exam**: Each visit

## Complications

### Acute
- [Diabetic Ketoacidosis](../procedures/dka-management.md)
- Hyperosmolar Hyperglycemic State
- Severe Hypoglycemia

### Chronic
- **Microvascular**:
  - Diabetic retinopathy
  - Diabetic nephropathy
  - Diabetic neuropathy
- **Macrovascular**:
  - Coronary artery disease
  - Cerebrovascular disease
  - Peripheral arterial disease

## Related Conditions
- [Hypertension](hypertension.md) - Often coexistent
- [Metabolic Syndrome](metabolic-syndrome.md)
- [Obesity](obesity.md)
- [Dyslipidemia](dyslipidemia.md)

## Key References
- [American Diabetes Association Standards of Care 2024](https://diabetesjournals.org/care/issue/47/Supplement_1)
- [AACE/ACE Diabetes Guidelines](https://www.aace.com/disease-state-resources/diabetes)
- [Metformin in Type 2 Diabetes - Cochrane Review](https://www.cochrane.org/CD002966/ENDOC_metformin-for-type-2-diabetes-mellitus)

## Recent Updates
- **2024**: New GLP-1 RA cardiovascular outcomes data
- **2023**: Updated insulin initiation guidelines

# Blood Pressure Measurement

## Equipment Needed
- Calibrated sphygmomanometer
- Appropriate cuff size
- Stethoscope

## Procedure Steps

```mermaid
graph TD
    A[Patient Preparation] --> B[Position Patient]
    B --> C[Select Appropriate Cuff]
    C --> D[Position Cuff]
    D --> E[Inflate Cuff]
    E --> F[Deflate Slowly]
    F --> G[Record Measurements]
    G --> H[Interpret Results]
```

## Step-by-Step Instructions

### 1. Patient Preparation
- Patient should rest 5 minutes before measurement
- Empty bladder if needed
- Avoid caffeine, exercise, smoking 30 minutes prior
- Remove tight clothing from arm

### 2. Positioning
- Seated comfortably with back supported
- Feet flat on floor
- Arm supported at heart level
- Palm facing upward

### 3. Cuff Selection
- Cuff bladder should encircle 80% of arm
- Width should be 40% of arm circumference

### 4. Measurement
- Inflate 20-30 mmHg above systolic pressure
- Deflate at 2-3 mmHg per second
- Record systolic (first sound) and diastolic (last sound)

## Normal Values
- **Normal**: <120/80 mmHg
- **Elevated**: 120-129/<80 mmHg
- **Stage 1 HTN**: 130-139/80-89 mmHg
- **Stage 2 HTN**: ≥140/90 mmHg

## Related Pages
- [Hypertension](../diseases/hypertension.md)
- [Cardiovascular Risk Assessment](cv-risk-assessment.md)

---
*Last updated: [Date] by [Physician Name]*
*Next review: [Date]*
